PMID- 7778531 OWN - NLM STAT- MEDLINE DCOM- 19950713 LR - 20190622 IS - 0002-9149 (Print) IS - 0002-9149 (Linking) VI - 75 IP - 18 DP - 1995 Jun 16 TI - Comparison of the safety and efficacy of delapril with captopril in outpatients with congestive heart failure. PG - 29F-36F AB - In this study delapril and captopril were compared in outpatients with congestive heart failure (CHF), New York Heart Association (NYHA) classes III and IV, in a double-blind study of efficacy and safety. Efficacy was evaluated by monitoring changes in the NYHA classification, exercise work, hemodynamic parameters, Kostuk's classification, and clinical signs and symptoms. Safety was monitored by a variety of laboratory tests, including renal and hepatic function, urinalysis, routine hematology testing, and the reporting of adverse events. Analysis of the data obtained revealed that delapril and captopril exhibit equal efficacy over the dosage ranges studied. There was a greater improvement of NYHA classification in terms of CHF signs and symptoms and ergometric workload in the delapril group; however, this did not reach statistical significance. The safety of the 2 drugs was also comparable, with no significant differences in any of the parameters measured at the start and end of the study. There was no statistically significant difference in the reporting of adverse events between the 2 drugs, although the sample size studied was small. There were no significant differences between the 2 drugs in terms of their effects on arterial blood pressure and no difference between prestudy and post-treatment arterial blood pressure measurements. FAU - Fuchs, W AU - Fuchs W AD - Takeda Pharma GmbH, Aachen, Germany. LA - eng PT - Clinical Trial PT - Clinical Trial, Phase III PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 RN - 0 (Angiotensin-Converting Enzyme Inhibitors) RN - 0 (Indans) RN - 9G64RSX1XD (Captopril) RN - W77UAL9THI (delapril) SB - IM MH - Administration, Oral MH - Adult MH - Aged MH - Aged, 80 and over MH - Ambulatory Care MH - Angiotensin-Converting Enzyme Inhibitors/administration & dosage/adverse effects/*therapeutic use MH - Captopril/administration & dosage/adverse effects/*therapeutic use MH - Double-Blind Method MH - Exercise Test/drug effects MH - Female MH - Heart Failure/*drug therapy/etiology/physiopathology MH - Humans MH - Indans/administration & dosage/adverse effects/*therapeutic use MH - Male MH - Middle Aged MH - Prospective Studies MH - Severity of Illness Index MH - Treatment Outcome EDAT- 1995/06/16 00:00 MHDA- 1995/06/16 00:01 CRDT- 1995/06/16 00:00 PHST- 1995/06/16 00:00 [pubmed] PHST- 1995/06/16 00:01 [medline] PHST- 1995/06/16 00:00 [entrez] AID - S0002-9149(99)80512-8 [pii] AID - 10.1016/s0002-9149(99)80512-8 [doi] PST - ppublish SO - Am J Cardiol. 1995 Jun 16;75(18):29F-36F. doi: 10.1016/s0002-9149(99)80512-8.